Bionote Inc. (377740) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Bionote Inc. (377740:KRX), powered by AI.

Current Price
₩4,750
P/E Ratio
-5.5
Market Cap
484.0B
Sector
Healthcare
What is the Bionote Inc. stock price forecast?

Bionote Inc. is currently trading at ₩4,750. View real-time AI analysis on Alpha Lenz.

What is Bionote Inc. insider trading activity?

View the latest insider trading data for Bionote Inc. on Alpha Lenz.

What is Bionote Inc.'s P/E ratio?

Bionote Inc.'s P/E ratio is -5.5.

Bionote Inc.

KRX · 377740
₩4,750-130(-2.66%)Market closedKRX regular session 09:00–15:30 KST
Ask about Bionote Inc.'s future dividend policy...
Alpha Chat Insight

Bionote Inc. trades at a P/E of -5.5 (undervalued) with modest ROE of -5.6%.

Ask for details

Company Overview

Bionote Inc. is a leading biotechnology firm specializing in the research, development, and commercialization of diagnostic solutions. The company's primary mission is to enhance human and animal health through innovative diagnostic products that enable early and accurate detection of diseases. With a focus on both human and veterinary applications, Bionote Inc. develops advanced testing kits and instruments which are essential for clinical laboratories, medical institutions, and veterinary practices. Its diagnostic solutions cover a wide spectrum of conditions, making it pivotal in sectors such as medical research, healthcare services, and animal care industries. In the financial market, Bionote Inc. represents a vital player in the growing biotechnology industry, which is of increasing importance due to the rising emphasis on disease prevention and health management. Positioned at the forefront of the diagnostic field, Bionote Inc. contributes to the advancement of medical sciences and public health initiatives across the globe.

CEO조병기
SectorHealthcare
IndustryMedical Devices
Employees313

Company Statistics

FY 2025

Profile

₩483,958,728,000Market Cap
₩118,323,544,200Revenue
101.89MShares Out
313Employees

Margins

55.58%Gross
-66.13%EBITDA
14.21%Operating
-74.01%Pre-Tax
-73.95%Net

Valuation

-5.53P/E
0.32P/B
4.09EV/Sales
-6.00EV/EBITDA
79.19P/FCF

Growth (CAGR)

-37.28%Rev 3Yr
-28.46%Rev 5Yr
-61.54%Op Inc 3Yr
-50.37%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-5.38%ROA
-5.56%ROE
-5.37%ROIC

Financial Health

₩17,870,634,530Cash & Cash Equivalents
₩26,774,670,700Net Debt
2.95%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Bionote Inc. (ticker: 377740) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 313 employees. Market cap is $484.0B.

The current price is ₩4,750 with a P/E ratio of -5.53x and P/B of 0.32x.

ROE is -5.56% and operating margin is 14.21%. Annual revenue is $118.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Bionote Inc. (377740) Stock Forecast 2026 ₩4,750 — Price, Financials & Analyst Targets | Alpha Lenz